Brief: Exagen May, From Time To Time, Continue To Issue, Sell Shares Of Common Stock, Having An Aggregate Offering Price Of Up To $50 Million
Nov 17 (Reuters) - Exagen Inc XGN.O :
* EXAGEN INC - ENTERED INTO AMENDMENT NO. 1 TO THAT CERTAIN
SALES
AGREEMENT, DATED SEPTEMBER 15, 2022
* EXAGEN INC: MAY, FROM TIME TO TIME, CONTINUE TO ISSUE,
SELL
SHARES OF COMMON STOCK, HAVING AN AGGREGATE OFFERING PRICE OF UP
TO $50 MILLION
Further company coverage: XGN.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Exagen
See all newsUS RESEARCH ROUNDUP-Analog Devices, IBM, Qualcomm
Exagen Inc. reports results for the quarter ended June 30 - Earnings Summary
Exagen Q2 revenue beats on test volume growth; raises 2026 outlook
Exagen Inc expected to post a loss of 19 cents a share - Earnings Preview
Exagen beats Q1 revenue estimates, reaffirms 2026 guidance